Q1: 2026-05-05 Earnings Summary

EPS of -$0.40 misses by $0.09

|

Revenue of

$10.79M

(0.81% Y/Y)

misses by $1.92M

Ocular Therapeutix, Inc. ( OCUL ) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDT

Company Participants

Pravin Dugel - Executive Chairman, President & CEO

Conference Call Participants

Tazeen Ahmad - BofA Securities, Research Division

Tara Bancroft - TD Cowen, Research Division

Presentation

Tazeen Ahmad

BofA Securities, Research Division

Ocular Therapeutics. Presenting for Ocular today and sitting up on stage with me is Dr. Pravin Dugel, who is, of course, CEO of the company. Dr. Dugel, I call you Pravin. Thank you for making the trip out here.

Pravin Dugel

Executive Chairman, President & CEO

Tazeen, thank you. Thanks for having us here. It's always a wonderful meeting and really appreciate the opportunity to speak with you and to be in this meeting. Thank you.

Tazeen Ahmad

BofA Securities, Research Division

I should actually refer to you as Dr.…